Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PISCES: Post-marketing study of adalimumab (Gelelix) in pediatric severe plaque psoriasis
CTR20230779Phase 4Completed
- Sponsor
- Bio-Thera Solutions, Ltd.
- Start
- Apr 2023
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of adalimumab in psoriasis, sponsored by Bio-Thera Solutions, Ltd.. Started Apr 2023; status: completed.
02
Drugs
03
Conditions
psoriasis
Beyond the preview
Go deeper on CTR20230779.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20230779.